[PDF] from 124.42.15.59PA Wachholz, JN Francis, MR Jacobson, I Kimber… - 2011 - 124.42.15.59 Background: Grass pollen immunotherapy for allergic rhinitis is a disease-modifying treatment that results in long-term clinical tolerance lasting years after treatment discontinuation. Active treatment is associated with generation of inhibitory grass pollen–specific IgG antibodies ... View as HTML
LK James, MH Shamji, SM Walker… - Journal of Allergy and …, 2011 - Elsevier We conducted a 4-year study in which patients who had moderate-to-severe allergic rhinitis underwent a randomized, double-blind, placebo-controlled discontinuation of subcutaneous grass pollen immunotherapy. All subjects received grass pollen immunotherapy injections for 2 years ... Cited by 8 - Related articles - All 4 versions
HP Moll, H Freudenthaler, A Zommer… - European journal of …, 2011 - Wiley Online Library ... Technical comment. Contamination with recombinant IFN accounts for the unexpected stimulatory properties of commonly used IFN-blockingantibodies. Herwig P. Moll 1,† ,; Harald Freudenthaler 1,† ,; Anna Zommer 1 ,; Elisabeth ... All 4 versions
C Evans, JW Gregory, J Barton… - Annals of Clinical …, 2011 - acb.rsmjournals.com We describe seven infants with transient congenital hypothyroidism (CH) due to maternal thyroid-stimulating hormone receptor (TSH-R) blocking antibodies (TRAb) identified over three decades of newborn screening for CH in Wales, UK that represents a minimum incidence ... Related articles - All 4 versions
R Aalberse - Allergy, 2011 - Wiley Online Library ... A second hypothesis is that IgG 4 antibodies act as blockingantibodies. This classical explanation states ... activation of mast cells. Blockingantibodies are thought to neutralize allergen so it no longer activates IgE-sensitized mast cells. ... Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
